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Objective To investigate whether birth weight and postnatal growth rates are independently related to the devel-
opment of overweight and wheeze up to age 3 years.
Study design Children from the LucKi Birth Cohort Study with complete follow-up for repeated questionnaires (at
age 0, 7, and 14 months and 3 years) and informed consent to use height and weight data (measured by trained
personnel at age 0, 7, and 14 months and 2 and 3 years) were included (n = 566). Wheeze (parental-reported)
and overweight (body mass index [BMI] >85th percentile) were regressed with generalized estimating equations
on birth weight and relative growth rates (difference SDS for weight, height, and BMI).
Results Higher birth weight and higher weight and BMI growth rates were associated with increased risk of over-
weight, but not of wheeze, up to age 3 years. Higher height growth rate was associated with lower risk of wheeze up
to 3 years, independent of overweight (aOR, 0.65; 95% CI, 0.53-0.79). In time-lag models, wheeze was associated
with subsequently reduced height growth up to age 14 months, but not vice versa.
Conclusion Only height growth rate, and not weight and BMI growth rate, is associated with preschool wheeze,
independent of overweight. Children who wheeze demonstrate a subsequent reduction in height growth up to age
14months, but not vice versa. Because height growth rate is not associatedwith overweight, preschool wheeze and
overweight are not associated throughout early life growth. (J Pediatr 2015;166:343-9).See editorial, p 226he prevalence of childhood asthma has increased in many countries.1 In parallel, rising trends in childhood overweightTand obesity have been observed.2 An association between asthma and overweight in children has been found in severalprospective studies.3 Proposed causal factors for this association include systemic inflammation, mechanical changes
associated with high body weight, changes in airway hyperresponsiveness, decreased physical activity, and changes in diet,4
but the exact pathways through which overweight may lead to asthma are currently poorly understood.5
Alternatively, overweight and asthma might not be causally related, but certain early life factors may play a role in the devel-
opment of both asthma and overweight independently. One such factor may be growth in fetal life and early life. In parallel with
somatic growth, development of the lungs starts in utero and continues after birth. After 16 weeks of gestation, the pattern of
the airway branching is complete, and thereafter the airways only grow in size and not in number.6 In contrast, the alveoli
develop mainly postnatally, from 36 weeks of gestation to at least 3 years after birth, and continue to increase in volume until
lung growth is completed in early adult life.7 Thus, reduced or accelerated growth in fetal and early life may disrupt normal
airway development and growth, leading to impaired function.
Birth weight, an indicator of fetal growth andmaturation, and postnatal growth are associated with wheeze/asthma and over-
weight. Both low and high birth weight seem to predispose for asthma8,9 and overweight,10-12 although studies report incon-
sistent findings. Unfavorable conditions in utero, such as maternal smoking during pregnancy,13 may cause impaired somatic
growth and impede lung development, thus explaining the risk of asthma in low birth weight children.9 In addition, low birthFrom the 1Department of Epidemiology, School of Public
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THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 166, No. 2prospective cohort study, we examined whether birth
weight and height, weight, and BMI growth rate are inde-
pendently related to wheeze and overweight in children
up to 3 years of age.
Methods
Data were obtained from the LucKi Birth Cohort Study, a
dynamic prospective cohort study conducted in the south-
eastern region of The Netherlands. LucKi is embedded in
the Dutch Child and Youth Health Care system, in which
children are followed longitudinally from birth through
routine visits at child health care centers. Most Dutch par-
ents (90%-95%) normally visit a child health care center
12 times between birth and age 4 years. Since July 2006,
all parents of newborn children who live in the study region
are invited to participate in LucKi starting at 1-2 weeks after
birth. Parents are asked to complete questionnaires at base-
line (1-2 weeks after birth) and when their child is aged
7 months, 14 months, and 3 years. The timing of the ques-
tionnaires coincides with routine visits. Parents are also
asked to provide signed informed consent for extracting
additional data from the Child and Youth Health Care
registry. The Lucki Birth Cohort Study was approved by
the Medical Ethical Committee of Maastricht University
Medical Center.
For the present study, inclusion criteria were birth between
July 2006 and December 2008, availability of all 4 question-
naires, and availability of parental informed consent. Exclu-
sion criteria were birth before 37 weeks gestation (because
of associated respiratory complications in preterm infants)
and multiple birth (because of associated lower gestational
age at birth and lower birth weight).
Anthropometric Measures
Birth weight was reported by the mother on the baseline
questionnaire and also was documented by Youth Health
Care personnel in the digital registry, based on information
obtained from the midwife or gynecologist present at birth.
Birth weight was treated as a continuous variable.
Weight, height, and BMI growth rates were determined
using data from the Child and Youth Health Care registry.
Nurse assistants measured the child’s height and weight at
each visit to the child health center in a standardized
manner. BMI was calculated by dividing weight (in kilo-
grams) by squared length (in meters). Relative growth rates
were calculated over 3 different age periods: 1-7 months, 7-
14 months, and 2-3 years. For each child, the height and
weight measurements recorded closest to these ages were
used in the analysis. If measurements were missing for a
certain age but other measurements were available, then
height and/or weight were estimated by linear interpolation
of surrounding measurements. SDSs were calculated for
height, weight, and BMI at age 1, 7, and 14 months and 2
and 3 years using the Dutch growth reference, standardized
for age at measurement and sex.23 For each growth charac-
teristic (weight, height, and BMI), the difference in SDS at344the end and the beginning of each time period was calcu-
lated. This difference score represents the child’s relative
growth rate in each period and was treated as a continuous
variable in the analyses.
Wheezing and Overweight
The primary outcome variable, wheeze, was determined at
age 7 months, 14 months, and 3 years, based on validated In-
ternational Study of Asthma and Allergies in Childhood
questions24 included in each follow-up questionnaire. Par-
ents were asked whether their child had wheezing or whis-
tling in the chest in the previous 7 months (questionnaires
at 7 and 14 months) or the previous 12 months (question-
naire at 3 years). A child was considered to have experienced
wheezing in a certain period if the parents answered ‘yes’ to
this question.
The secondary outcome variable, overweight, was deter-
mined using BMI at age 7 months, 14 months, and 3 years.
Because no cutoff values for overweight exist for children
younger than 2 years old, we classified children with an
age- and sex-specific BMI above the 85th percentile of the
present study population as overweight.25
Potential Confounders
Information on potential confounders was collected by ques-
tionnaires and from the registry. Data on sex, gestational age,
number of older siblings, maternal smoking during preg-
nancy, and parental history of atopy were available from
the baseline questionnaire. Breastfeeding duration, day care
attendance, and environmental tobacco smoke were reported
in the follow-up questionnaires at age 7 months, 14 months,
and 3 years. We cross-checked variables that were also avail-
able from the registry: sex, gestational age at birth, and smok-
ing during pregnancy.
The variables breastfeeding duration, day care attendance,
and environmental tobacco smoke were defined for each time
period (0-7 months, 7-14months, and 2-3 years). Breastfeed-
ing duration was defined as the number of months per period
that the child received breast milk, exclusively or partially. All
potential confounders, except breastfeeding duration, were
treated as categorical variables in the analyses. Missing values
were replaced with the value of the most frequent category.
Statistical Analyses
We applied univariable and multivariable logistic generalized
estimating equations (GEE) models with exchangeable corre-
lation structure, for birth weight and weight, height, and BMI
growth rates separately. The GEE approach is especially suit-
able for analysis of longitudinal data with repeated measure-
ments.26 In multivariable analyses, we adjusted for all of the
aforementioned potential confounders simultaneously.
Multivariable models with relative growth rates as determi-
nants were also adjusted for birth weight. An interaction
term was added to the models to explore possible differences
in associations between age periods, with the interaction var-
iable age period coded as 7, 14, or 36 (reflecting age at mea-
surement in months).de Korte-de Boer et al
Table I. Baseline characteristics of the present study
population and the total eligible study population in the
LucKi cohort
Characteristics
Total eligible
study population
(n = 2166)*
Present study
population
(n = 566)†
Male sex, n (%) 1066 (49.4) 296 (52.3)
Gestational age at birth, n (%)
37-38 wk 488 (22.5) 118 (20.8)
39-40 wk 1123 (51.8) 288 (50.9)
41-42 wk 545 (25.2) 159 (28.1)
Missing 10 (0.5) 1 (0.2)
Birth weight, g, mean (SD) 3467 (491) 3457 (484)
Breastfeeding duration
0-7 mo, n (%) 344 (60.8)
Mo, mean (SD) 2.6 (2.8)
7-14 mo, n (%) 114 (20.1)
Mo, mean (SD) 0.7 (1.7)
Parental history of atopy, n (%)
No 704 (32.5) 184 (32.5)
Maternal 613 (28.3) 163 (28.8)
Paternal 382 (17.6) 90 (15.9)
Both parents 457 (21.1) 125 (22.1)
Missing 10 (0.5) 4 (0.7)
Smoking during pregnancy, n (%) 271 (12.5) 56 (9.9)
Environmental tobacco smoke, n (%)
0-7 mo 43 (7.6)
7-14 mo 37 (6.5)
2-3 y 50 (8.8)
Missing 8 (0.1)
Day care attendance, n (%)
0-7 mo 313 (55.3)
7-14 mo 346 (61.1)
2-3 y 496 (87.6)
Older siblings, n (%)
None 915 (42.2) 246 (43.5)
One or more 1068 (49.3) 265 (46.8)
Unknown 183 (8.4) 55 (9.7)
*Single birth children born between July 2006 and December 2008 after more than 36 weeks of
gestation.
†Selection of children with complete follow-up (questionnaires and informed consent for using
data from the Youth Health Care registry).
February 2015 ORIGINAL ARTICLESResults are presented as ORs with 95% CIs. A P value <.05
was considered statistically significant. Data were analyzed
with SPSS version 20.0 (IBM, Armonk, New York).
Results
Between July 2006 andDecember 2008, a total of 2317 children
were enrolled in the LucKi Birth Cohort Study shortly after
birth (representing 65% of all births in the study region).
For the present study, we excluded twins (n = 36) and children
born before 37 weeks gestation (n = 131, 16 of whom were
twins), leaving 2166 children who met the eligibility criteria.
All completed questionnaires and informed consent for the
use of registry data were available for 566 of these children
(26.1%). Compared with the total group of eligible children
within the LucKi study, the present study population of 566
subjects included slightlymore boys and slightly fewer children
whose mother had smoked during pregnancy. Other charac-
teristics were similar in the 2 cohorts (Table I).
Wheezing and Overweight
Parents of 75 of the 566 children (13.3%) reported wheeze
between birth and age 7 months, of whom 4 (5.3%) had
ever been diagnosed with asthma by a physician. Further-
more, 28 of the 75 children (37.3%) with reported wheezing
before age 7 months had ever used medication for their
symptoms, with 22 (29.3%) using a bronchodilator and 1
(1.3%) using a corticosteroid. At age 14 months, 107 of the
566 children (18.9%) had reported wheezing in the previous
7 months, of whom 39 (36.4%) also wheezed before age
7 months and 8 (7.5%) had ever been diagnosed with asthma
by a physician. Furthermore, 44.9% (48 of 107) of the chil-
dren with wheezing between age 7 and 14 months had ever
used medication for wheeze or asthma, with 35 (32.7%) us-
ing a bronchodilator and 5 (4.7%) using a corticosteroid.
At age 3 years, 75 children (13.3%) had reported wheeze in
the previous year, of whom 50 (66.7%) also wheezed before
age 7 months and/or before age 14 months and 13 (17.3%)
had ever been diagnosed with asthma by a physician.
Furthermore, 49 of 75 children (65.3%) with wheeze between
age 2 and 3 years had ever used medication for wheeze or
asthma, with 36 (48.0%) using a bronchodilator and 4
(5.3%) using a corticosteroid.
Mean BMI (kg/m2) was 16.91 (range, 12.91-21.13) at age
7 months, 16.96 (range, 13.35-21.38) at age 14 months, and
15.82 (range, 12.79-20.31) at age 3 years. Cutoff points for
the 85th percentile BMI were 18.75 for boys and 17.99 for
girls at age 7 months, 18.58 for boys and 18.03 for girls at
age 14 months, and 16.94 for boys and 16.92 for girls at age
3 years.
Using univariable logistic GEE analyses, we calculated the
association between overweight (determinant) and wheeze
(outcome) in our population. We found that overweight
was associated with wheeze at age 7 months (crude OR,
1.84; 95% CI, 1.12-3.03), but not at 14 months (crude OR,
1.19; 95% CI, 0.82-1.74) or 3 years (crude OR, 0.77; 95%
CI, 0.43-1.40).Early Life Growth and the Development of Preschool Wheeze, In
The LucKi Birth Cohort StudyAssociations of Birth Weight and Relative Growth
Rates with Overweight
Higher birth weight and higher weight and BMI growth rates
were associated with increased risk of overweight up to age
3 years (aOR, 1.50 [95% CI, 1.23-1.83] for each 500-g incre-
ment in birth weight, and aOR 2.33 [95% CI, 1.98-2.75] and
aOR 2.47 [95% CI, 2.11-2.90], respectively, for a 1 SDS incre-
ment), but height growth rate was not associated with over-
weight (Table II). There was a significant interaction of
weight growth rate and age (Pinteraction < .001); the
association between weight growth rate and overweight
became stronger with increasing age (aOR 1.98 [95% CI,
1.66-2.38] at age 7 months, 3.21 [95% CI, 2.49-4.13] at age
14 months, and 5.17 [95% CI, 3.16-8.46] at age 3 years).
Associations of Birth Weight and Relative Growth
Rates with Wheezing
Birth weight and weight and BMI growth rates were not asso-
ciated with wheeze up to age 3 years (aOR, 1.02 [95% CI,
0.83-1.240 per 500 g, and aOR 0.88 [95% CI, 0.73-1.05]
and aOR, 1.16 [95% CI, 0.99-1.37] per SDS, respectively).dependent from Overweight: 345
Table II. Associations of birth weight and weight, height, and BMI growth rates with overweight, wheeze, and wheeze
independent of overweight in children up to age 3 years
Determinant Overweight Wheeze Wheeze independent of overweight*
Birth weight (per 500 g)
Crude OR (95% CI) 1.48 (1.24-1.76) 1.09 (0.92-1.30)
aOR (95% CI)† 1.50 (1.23-1.83) 1.02 (0.83-1.24) 1.00 (0.82-1.22)
Weight growth rate (per SDS)
Crude OR (95% CI) 1.95 (1.69-2.24)x 0.89 (0.74-1.05)
aOR (95% CI)z 2.33 (1.98-2.75)x 0.88 (0.73-1.05) 0.85 (0.71-1.03)
Height growth rate (per SDS)
Crude OR (95% CI) 1.05 (0.89-1.24) 0.66 (0.55-0.80)
aOR (95% CI)z 1.12 (0.94-1.33) 0.65 (0.54-0.73) 0.65 (0.53-0.79)
BMI growth rate (per SDS)
Crude OR (95% CI) 2.20 (1.91-2.54) 1.16 (0.99-1.36)
aOR (95% CI)z 2.47 (2.11-2.90) 1.16 (0.99-1.37) 1.15 (0.98-1.36)
ORs with 95% CIs were calculated from GEE logistic regression analyses, with an exchangeable correlation structure. Wheeze, overweight, and growth rates have been measured repeatedly in 3 time
periods (age 0-7 months, age 7-14 months, and age 2-3 years). Statistically significant associations (P < .05) are displayed in bold type.
*By adding overweight as determinant in the multivariable models.
†Adjusted for sex, gestational age, older siblings, parental history of atopy, smoking during pregnancy, breastfeeding duration, day care attendance, and environmental tobacco smoke.
zAdjusted for birth weight, sex, gestational age, older siblings, parental history of atopy, smoking during pregnancy, breastfeeding duration, day care attendance, and environmental tobacco smoke.
xInteraction of determinant with age period is statistically significant (P < .001).
Figure 2. Associations of wheeze with subsequent height (in
cm) up to age 3 years. Data are B coefficients with 95% CIs
from linear time-lag GEE analyses for each age period. B
coefficients represent the difference in height (in cm) between
children who wheezed in the previous period compared with
children who did not wheeze in that period, controlling for
height at the end of the previous period.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 166, No. 2A higher height growth rate was associated with lower risk of
wheeze up to age 3 years (aOR, 0.65 [95% CI, 0.54-0.73]
per aSDS) (Table II). The associations of birth weight, and
weight, height, or BMI growth rates with wheeze did not
change much with inclusion of overweight in the models
(Table II).
To explore the direction of the association between height
growth and wheeze, we designed 2 time-lag models. The first
model (A, height/wheeze) included wheeze in age period t
[wheeze(t)] as a function of height at the end of the previous
age period [height(t  1)], while controlling for wheeze in
the previous age period [wheeze(t  1)]. The second model
(B, wheeze/height) included height(t) as function of
wheeze in the previous period [wheeze(t  1)], controlling
for height at the end of that period [height(t  1)]. The re-
sults of logistic (model A) and linear (model B) GEE analyses
are displayed in Figure 1 (available at www.jpeds.com). In
time-lag model A, the risk of wheeze(t) was positively
associated with height in the previous period (OR, 1.05
[95% CI, 1.02-1.07] per cm of body height); that is,
children who were taller in the previous period had a
slightly greater risk of developing wheeze, which is in
contradiction to the association found in the main model.
In time-lag model B, height(t) was lower after a previous
period of wheeze (B, 0.30; 95% CI, 0.69 to 0.10), which
is in line with the negative association between height
growth rate and wheeze found in the main model.
Because the interaction term of wheeze(t  1) with age
period was statistically significant in model B (Pinterac-
tion < .001), we repeated the analyses for each age period.
We found that the negative association of height with previ-
ous wheeze was strongest in the first 7 months (difference in
height growth [cm] between wheezers and nonwheezers: B,
1.23; 95% CI, 2.15 to 0.31), attenuated by age
14 months (B,0.51; 95% CI,0.92 to0.10), and had dis-
appeared by age 3 years (B, 0.22; 95% CI, 0.26 to 0.70)
(Figure 2).346Sensitivity Analyses
To check for a nonlinear association between birth weight
and the outcome variables wheeze and overweight, we added
a centralized quadratic term for birth weight to the univari-
able models. The quadratic term was not statistically signifi-
cant in any model, and thus we dropped it from all models.
To verify the existence of nonlinear associations involving
BMI (ie, parabolic or U-shaped), we performed 2 sensitivity
analyses. First, we repeated all analyses after excluding chil-
dren with a BMI below the 15th percentile, which resulted
in similar associations. Second, instead of defining over-
weight as a binary variable based on the 85th percentile of
the BMI distribution, we used a centralized, quadratic termde Korte-de Boer et al
February 2015 ORIGINAL ARTICLESof BMI as a continuous variable in the models with wheeze as
the outcome variable. In all models, the quadratic term for
BMI was not statistically significant.
The use of a cutoff point of the 85th percentile of BMI to
define overweight is arbitrary, especially for children under
age 2 years. Thus, we repeated the analyses using cutoff
points for the 90th and 95th percentiles of BMI, but this
did not change the results. We also repeated the analyses
using cutoff points for 3-year-old boys and girls of a widely
used international standard,27 which were lower than the
cutoff points for the 85th percentile of BMI. Instead of
85 children (15%) with a BMI in the 85th percentile, only
37 children (6.2%) in our study population were overweight
according to the international standard. Nevertheless, using
these different cutoff points for 3-year-old children did not
change our results.
Finally, to increase comparability between our study and
others, we repeated our univariable logistic GEE analyses
with wheeze as the outcome and relative growth rates be-
tween 1 and 3 months as the determinant. We found associ-
ations similar to the original analyses but with slightly
broader CIs, indicating that more precision in the estimates
is achieved by including multiple growth rate periods in
the analyses.
Discussion
Our findings show that in preschool children, only height
growth rate is associated with wheeze, independent of over-
weight, and that birth weight, weight growth rate, and BMI
growth rate are associated with overweight only. Thus, early
life growth rates cannot explain an association between pre-
school wheeze and overweight. Furthermore, time-lag ana-
lyses revealed that wheeze is associated with subsequently
reduced height growth up to age 14 months, but not vice
versa.
Our findings are in contrast with those of other studies on
the association between early life growth patterns and
wheeze, which identified an association of weight growth16-
20 but no association of height growth16-19 with later wheeze
and/or asthma. In line with our findings, 2 other studies
found no association between weight growth and later
wheeze,21,22 but no other study has reported an association
of height growth and wheeze. Furthermore, we could not
confirm an association of (high or low) birth weight with
wheeze as has been found in some studies,9 although not in
others.18,22
Such conflicting results may derive from differences
in methodological choices, such as definition of growth
rates and timing of outcome measurements. In our study,
growth was defined as difference scores of standardized
weight, height, or BMI in 3 periods (age 1-7 months, age
7-14 months, and age 2-3 years), whereas others have cate-
gorized growth between age 0 and 2 years21 or in several
intermediate periods16-18 into slow, normal, and rapid
weight gain, or have used parameters of modeled growthEarly Life Growth and the Development of Preschool Wheeze, In
The LucKi Birth Cohort Studycurves to define growth patterns.19,20,22 Sensitivity analyses
with relative growth rates calculated over 1-3 months only
as a determinant did not change our conclusions, however.
Results of studies that focused solely on BMI as marker for
growth may be influenced by an inverse association of
height growth with wheeze as we found in the present study,
by inaccurately attributing an effect to weight gain instead
of reduced height growth, emphasizing the importance of
studying weight and height separately.
Another difference is that we used repeatedly measured
wheeze as an outcome measure, whereas in other studies
the outcomes were measured only once or were combined
into a single endpoint (eg, ever wheeze). Although our sam-
ple size is smaller than that of some other studies, we achieved
sufficient statistical power to detect a statistically significant
negative association between height growth and wheeze. In
addition, some other studies measured outcomes in school-
aged children. In preschool children, wheeze is more preva-
lent and associated mainly with viral infections, whereas in
older children with persistent wheeze up to age 6 years and
older, wheeze is associated mainly with atopy.28 Thus, it is
likely that not all children with wheeze symptoms in our
study population will go on to develop allergic asthma as
they age.
Our results indicate that most likely different mechanisms
are responsible for the association of growth with overweight
and for the association of growth with wheeze in preschool
children. In the association with overweight (based on
BMI), weight gain seems to play a key role, and in the asso-
ciation with wheeze, reduced height is primarily involved.
Because overweight and weight gain are by definition closely
related, a strong association between weight growth rate and
overweight was to be expected in our study. In the absence of
an association of weight growth rate and wheeze, however,
our results do not confirm a causal relation between over-
weight and wheeze/asthma through pathways related to
high body weight, such as increased visceral fat deposition,
mechanical changes, and low-grade systemic inflammation.
Rather, the (nonsignificant) estimates of the association be-
tween weight growth rate and wheeze point to a protective ef-
fect of weight growth rate for preschool wheeze in our study
population.
From our time-lag models, we conclude that in the associ-
ation of height and wheeze, reversed causation was intro-
duced; wheeze was associated with subsequently reduced
height growth, but not vice versa. This eliminates the possi-
bility that restricted height growth affects airway growth
and thereby leads to respiratory problems. Potential explana-
tions for height growth restriction in children with wheeze
include an adverse effect on growth of asthma medication,
such as inhaled corticosteroids29; comorbidities of wheeze/
asthma, such as gastroesophageal reflux disease,30 which
may hinder sufficient nutrient intake31 and thereby lead to
reduced height growth; or the presence of an underlying con-
dition, for instance, a respiratory tract infection, that induces
wheeze episodes and may as well cause temporal growthdependent from Overweight: 347
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 166, No. 2restriction. The latter explanation is supported by the fact
that the association between wheeze and height growth dis-
appears at age 3 years, because older children are less suscep-
tible to viral infections. The use of corticosteroids was low in
this young population (1.3%-5.3% of the children with re-
ported wheeze) and thus is an unlikely explanation for our
findings.
Strengths of the present study are its prospective design
and the use of repeatedly measured outcome measures.
Also, because trained nurse assistants measured height and
weight in a standardized manner, bias associated with self-
reporting of height and weight (eg, social desirability bias,
recall bias) was eliminated.32 Furthermore, the use of stan-
dardized International Study of Asthma and Allergies in
Childhood questions to measure the outcome of wheezing
permits comparison with other studies.
This study is also subject to some limitations. First, selec-
tion bias may have been introduced. Our study population
was largely comparable with the total group of eligible chil-
dren, but with slightly more boys and slightly less children
whose mother had smoked during pregnancy. Additional
exploration indicated that in the group with complete
follow-up, the prevalence of wheeze was slightly higher
(data not shown). Because boys are more likely to wheeze
than girls, and because mothers of lower socioeconomic sta-
tus are more likely to smoke during pregnancy, these differ-
ences likely indicate that parents of children with respiratory
symptoms and parents with higher socioeconomic status
were more inclined to complete all questionnaires in the
LucKi Birth Cohort Study. This has implications for the
generalizability of our results, but because we adjusted for
sex and smoking during pregnancy in our multivariable an-
alyses, and because other related characteristics, such as
birth weight, were comparable, the internal validity of the
present study likely is not threatened. Moreover, repeating
our crude analyses with children with less-complete
follow-up for questionnaires yielded similar associations of
relative growth rates and wheeze (data not shown). The
exclusion of preterm and multiple-birth children means
that the present study results cannot be generalized to these
specific groups.
Second, the study’s observational design leaves the possi-
bility of residual confounding in the analyses, for example,
because we lacked data on maternal height and weight.
Nonetheless, we were able to control our analyses for
many potential confounders, some of which were also
measured repeatedly over the study period. A third limita-
tion is the use of BMI cutoff points for overweight in chil-
dren younger than 2 years. The use of BMI as a proxy for
visceral fat mass is currently a topic of debate, and there is
no internationally validated cutoff point for children under
age 2 years. We believe that our use of BMI cutoff points for
the purpose of defining (changes in) overweight in our
study population is justified, supported by the fact that us-
ing different cutoff points in the sensitivity analyses did not
change the results. n348The authors wish to thank all parents and their children for partici-
pating in LucKi, and the co-workers of Orbis Jeugdgezondheidszorg
for collecting the data.
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